Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
March 30 2021 - 6:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF
REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT
OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS
13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-37508
NEOS THERAPEUTICS,
INC.
(Exact name of registrant as specified in its charter)
2940 N. Highway 360
Grand Prairie, TX 75050
(972) 408-1300
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
(Title of each class of securities covered by this
Form)
None
(Titles of all other classes of securities for which
a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
|
|
Rule 12g-4(a)(2)
|
|
☐
|
|
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
|
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
|
|
Rule 15d-6
|
|
☐
|
|
|
Rule 15d-22(b)
|
|
☐
|
|
|
Approximate number of holders of record as of the certification
or notice date: One
Pursuant to the requirements of the Securities Exchange Act of 1934,
Neos Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
NEOS THERAPEUTICS, INC.
|
|
|
|
|
Date: March 29, 2021
|
|
|
|
By:
|
|
/s/ Joshua Disbrow
|
|
|
|
|
|
|
Name: Joshua Disbrow
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Apr 2023 to Apr 2024